^
BIOMARKER:

H3.3K27M

i
Other names: H3, histocompatibility 3, H-3
H3.3K27M
Glioma
ONC201
Sensitive: B - Late Trials
H3.3K27M
Glioma
bevacizumab + ONC201
Sensitive: C3 – Early Trials
H3.3K27M
Glioma
temozolomide
Sensitive: C4 – Case Studies
H3.3K27M
Glioma
panobinostat
Sensitive: D – Preclinical
H3.3K27M
Glioma
Hypomethylating agent
Sensitive: D – Preclinical